Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Absence of Pharmacokinetic Interactions between the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib and Methotrexate.
J Pharmacol Exp Ther. 2019 Oct;371(1):202-207. doi: 10.1124/jpet.119.257089. Epub 2019 Aug 1.
J Pharmacol Exp Ther. 2019.
PMID: 31371481
Clinical Trial.
Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Volunteers Treated With GDC-0853, a Selective Reversible Bruton's Tyrosine Kinase Inhibitor.
Herman AE, Chinn LW, Kotwal SG, Murray ER, Zhao R, Florero M, Lin A, Moein A, Wang R, Bremer M, Kokubu S, Serone AP, Hanze EL, Viberg A, Morimoto AM, Winter HR, Katsumoto TR.
Herman AE, et al. Among authors: florero m.
Clin Pharmacol Ther. 2018 Jun;103(6):1020-1028. doi: 10.1002/cpt.1056. Epub 2018 Mar 23.
Clin Pharmacol Ther. 2018.
PMID: 29484638
Clinical Trial.
Item in Clipboard
Impact of multiple lymphatic channel drainage to a single nodal basin on outcomes in melanoma.
Wall JK, Florero M, Accortt NA, Allen R, Kashani-Sabet M, Morita E, Leong SP.
Wall JK, et al. Among authors: florero m.
Arch Surg. 2007 Aug;142(8):753-7; discussion 756-8. doi: 10.1001/archsurg.142.8.753.
Arch Surg. 2007.
PMID: 17709729
Item in Clipboard
Cite
Cite